New Jersey will receive nearly $125 million as part of a settlement agreement reached with OxyContin maker Purdue Pharma over ...

Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the ...

South Carolina is set to receive nearly $73 million as part of a multi-billion-dollar settlement with pharmaceutical ...

All 50 states, Washington, D.C., and four U.S. territories have signed on to a $7.4 billion settlement with Purdue Pharma, ...

The $7.4 billion nationwide settlement with provide state and local governments with funds for opioid treatment efforts, said ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of ...

Georgia could receive up to $126 million from a national opioid settlement with Purdue Pharma and the Sackler family.

Purdue Pharma has gained support from attorneys general in 55 U.S. states and territories for a $7.4 billion settlement aimed ...

Ohio will receive up to $198 million from a $7.4 billion opioid settlement with Purdue Pharma and the Sacklers.

All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.

More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler ...

Attorney General Andrea Campbell said the settlement can't bring back lives lost, but "will bring in much-needed funds to ...